Trusted Monoclonal Antibodies, Direct from the Source
We’re the original manufacturer behind the antibodies you rely on — now delivering unmatched quality and specificity straight to your lab.
The Experts Behind the Antibodies You Trust
We’re not just another supplier — we’re the original developers and manufacturers of the monoclonal antibodies and recombinant proteins that power groundbreaking research and innovation. For decades, our products have set the benchmark for quality and specificity across academia, biotech, and diagnostics.
Dr. Tandon is the President and CEO of NEOBIOTECHNOLOGIES, a leading antibody company based in Silicon Valley, California. His passion for antibodies is evident in all he does and has been a pioneer in the antibody industry for the past four decades.
Unrivaled Validation for Research You Can Trust
At NeoBiotechnologies, we offer the most stringently validated primary antibodies on the market — delivering the reliability and reproducibility your research demands.
Ensuring Experimental Accuracy
Reliable results start with the right reagents. Our antibodies undergo thorough validation processes to ensure specificity, sensitivity, and reproducibility across applications like Western blotting, immunofluorescence, flow cytometry, and more. Don't leave your data to chance—choose antibodies that are tested and trusted by researchers worldwide.
The Importance of Antibody Validation
Antibodies are critical tools in the quest to understand fundamental biological processes, diagnose diseases and develop new therapies.
Application Validation
Additionally, we assist in confirming the functionality of the antibody in specific application(s) of interest. Application verification is employed to guarantee the antibody’s efficacy not only in a singular application but also across various other applications, demonstrating its accurate target binding.
Sequencing
One aspect that sets NeoBiosciences apart from other antibody manufacturers is that we sequence all our products. This added quality control step ensures reproducibility and lot-to-lot consistency.
Enhanced Validation
At NeoBiotechnologies, we use both Protein Array analysis and Tissue Microarrays (TMAs) as powerful tools in our antibody validation process.
The NeoBiotechnologies Difference: Unmatched Specificity, Unrivaled Confidence
At NeoBiotechnologies, we go beyond standard antibody production. Every monoclonal antibody we offer is validated through the most stringent, application-specific testing to ensure true monospecificity and consistent performance.
Relentless Quality. Proven Results.
At NeoBiotechnologies, excellence isn’t optional — it’s built into everything we do. Our scientists have screened millions of antibodies to curate a best-in-class portfolio targeting the human proteome. With a 98% rejection rate, only the highest-performing antibodies make it through our rigorous selection process.
Cyclin E (G1/S-Phase Cyclin) Antibody
Explore our featured antibody: Cyclin E (G1/S-Phase Cyclin)—critical for cell cycle research and CDK regulation.
Stay Updated with NeoBiotechnologies
Explore the newest developments, product launches, scientific breakthroughs, and company updates from NeoBiotechnologies.
Shop Highly Validated Monoclonal Antibodies—Backed by HuProt™ MicroArray Results.
What Researchers Are Saying
At NeoBiotechnologies, our commitment to quality and precision is reflected in the success of our customers. Here’s what researchers and institutions around the world have to say about working with our antibodies.
Stay Connected
Be the first to hear about new antibody releases, validation updates, research insights, and special promotions from NeoBiotechnologies. Join our scientific community and stay one step ahead in your research.